FDA grants AP status for Simvastatin ANDA076685 by Watson Labs Teva
The FDA has granted approval status (AP) for the Abbreviated New Drug Application (ANDA076685) for Simvastatin submitted by Watson Labs Teva.
Company
Pharmaceutical intelligence for Watson Labs Teva with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.